SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000904454-09-000722
Filing Date
2009-11-24
Accepted
2009-11-24 17:41:42
Documents
1
Period of Report
2009-11-20

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 4551
  Complete submission text file 0000904454-09-000722.txt   6465
Mailing Address ONE PALMER SQ STE 515 PRINCETON NJ 08542
Business Address ONE PALMER SQ STE 515 PRINCETON NJ 08542
DP VII ASSOCIATES LP (Reporting) CIK: 0001372932 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33415 | Film No.: 091205772

Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Issuer) CIK: 0001382911 (see all company filings)

IRS No.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations